Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants
Clinical trial NCT05213481 · COMPLETED
Trial details
- NCT number
- NCT05213481
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2022-05-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.